Department Of Pediatric Oncology
Investigator
Luca Szalontay, MD
Phone
212-305-9770
Email
ls3399@cumc.columbia.edu
(Biography not available)
Clinical Studies Managed By This Investigator:
Condition Study Title
Cancer A Study for Patients with Advanced Melanoma, Solid Tumors or Lymphoma Using Study Drug Pembrolizumab
Pediatric Solid Tumors [ CLOSED ] Study of Selinexor in Pediatric Solid Tumors, including CNS Tumors
Pediatric Solid Tumors [ CLOSED ] Testing combination drugs in children with solid tumors that have come back or are resistant to current anti-cancer therapy
Cancer [ CLOSED ] Safety, Tolerability, Efficacy and Pharmacokinetics of Copanlisib in Pediatric Patients (6 months-17 years)
Cancer [ CLOSED ] Safety, Tolerability, Efficacy and Pharmacokinetics of Copanlisib in Pediatric Patients (ages 18-21)
Cancer Study Of Palbociclib Combined With Chemotherapy In Pediatric Patients With Recurrent/Refractory Solid Tumors
Leukemia [ CLOSED ] MLN4924 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome (18 to 21 years old)
Childhood Leukemia [ CLOSED ] MLN4924 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome (1 month to 17 years old)
Cancer [ CLOSED ] Study of Flotetuzumab for Children, Adolescents, and Young Adults with Relapsed or Refractory Acute Myeloid Leukemia (AML)
Cancer Study of MTX110 in Combination with Gadolinium in Children with Newly Diagnosed Brain Cancer (Diffuse Midline Gliomas)
Brain Cancer Study of MTX110 in Combination with Gadolinium in Children & Young Adults with Newly Diagnosed Brain Cancer (Diffuse Midline Gliomas)
Brain Tumors Study of MTX110 in Combination with Gadolinium in Children with Newly Diagnosed Brain Cancer (Diffuse Midline Gliomas)
This website uses cookies as well as similar tools and technologies to understand visitors’ experiences. By continuing to use this website, you consent to Columbia University’s usage of cookies and similar technologies, in accordance with the Columbia University Website Cookie Notice.
I AGREE